Prophet Walter Magaya is reportedly preparing to introduce a new initiative called “Water of Life” at the Night of Turnaround gathering on November 6, 2026. Details regarding the nature and purpose of the initiative remain unclear.
HARARE, Zimbabwe — Prophet Walter Magaya is reportedly preparing to introduce a new initiative called “Water of Life” at the annual Night of Turnaround gathering on November 6, 2026, drawing attention to the need for clear information about the initiative, particularly if it involves products promoted for health or healing.
A report published by The Observer Zim on October 26 said the launch was expected to be one of the highlights of the event organised by Magaya’s Prophetic Healing and Deliverance (PHD) Ministries. The publication said further details about the initiative were expected to be revealed during the programme.
However, the report did not establish that Water of Life is a medicine, nor did it document claims that the initiative can cure cancer, HIV/AIDS, infertility, unemployment or other conditions. Those claims should therefore not be attributed to Magaya or his ministry as established facts without a verifiable statement or other reliable evidence.
The distinction is important because religious gatherings often include prayer, testimonies and expressions of faith, while claims that a substance can treat or cure a disease raise separate questions about evidence, product safety and regulatory approval.
What is known about the planned launch?
According to the published announcement, Water of Life is expected to be introduced during the November 6 Night of Turnaround gathering. The report also referred to Magaya’s period of fasting and prayer ahead of the event.
Beyond those details, publicly available information identified in this report does not establish the initiative’s ingredients, intended use, manufacturer or regulatory status. It is also unclear whether the name refers to a spiritual programme, a physical product, or another type of initiative.
These details matter because the name alone cannot determine whether a product is subject to medicines regulation. Its ingredients, intended purpose, method of promotion and any health claims made about it would help establish which requirements apply.
A clear announcement from the ministry explaining what Water of Life is intended to do would help worshippers, health professionals and the public distinguish its spiritual purpose, if any, from claims that would require medical evidence.
What happened in the Aguma case?
The renewed attention comes against the background of a previous controversy involving Magaya and a product called Aguma.
In October 2018, Magaya announced that Aguma could cure HIV/AIDS and made claims about its ability to treat other illnesses. The claims prompted scrutiny from health authorities and law enforcement agencies.
On February 5, 2019, The Herald reported that Magaya had been convicted and fined US$700 after pleading guilty to contravening the Medicines Control Act in connection with the announcement and promotion of the purported HIV/AIDS cure. The report said the court focused on the failure to follow the required procedures for handling and promoting the medicine.
The case is relevant because it illustrates the legal and public-health risks that can arise when a product is promoted as a cure before the applicable regulatory requirements have been met.
It is equally important to describe the outcome accurately. The conviction concerned the breach of medicines-control requirements; it should not be misrepresented as a scientific trial establishing the effectiveness or ineffectiveness of every substance associated with the case. Magaya maintained at the time that Aguma was authentic, according to contemporary reporting.
The historical case does not establish that Water of Life is the same product, that it contains medicinal ingredients, or that the same conduct has occurred again. Those questions require evidence specific to the new initiative.
What does Zimbabwe’s medicines regulator do?
The Medicines Control Authority of Zimbabwe (MCAZ) is responsible for evaluating medicines and issuing marketing authorisation for products within its regulatory remit. Its official online registers provide a route for checking the status of approved human, veterinary and complementary medicines.
MCAZ guidance on complementary medicines explains that products intended for public use are subject to assessment under the applicable regulatory framework. It also notes that not every medicinal claim is permitted.
This means that if Water of Life is a product intended to prevent, treat or cure a medical condition, its classification and regulatory status would need to be established before conclusions could be drawn about whether it may lawfully be marketed or promoted for that purpose.
The public should not assume that a product is approved simply because it is introduced at a large religious gathering, endorsed by a prominent individual or described as natural. Equally, the product should not automatically be described as unregistered or unlawful without checking the relevant records and obtaining clarification from the responsible authority.
A formal statement from MCAZ could establish whether the initiative involves a regulated product, whether an application or authorisation exists, and what restrictions apply to any medical claims.
Why claims about serious illnesses require care
Claims involving cancer and HIV/AIDS deserve particular scrutiny because people living with these conditions may be vulnerable to misleading promises of a cure.
A person who delays or stops prescribed treatment because they believe an unverified product will cure an illness could face serious health consequences. This risk exists regardless of whether the claim comes from a religious leader, a commercial company, a social media personality or another source.
Faith and medical care do not have to be presented as opposing choices. People can seek spiritual support while continuing to receive appropriate medical care and advice from qualified health professionals.
Anyone considering a product advertised for a medical purpose should seek reliable information about its ingredients, safety, evidence of effectiveness and regulatory status. People living with HIV should continue to follow the advice of their healthcare providers and should not stop antiretroviral treatment because of an unverified cure claim. Anyone undergoing cancer treatment should similarly consult their oncology team before changing or replacing treatment.
The same caution applies to claims about infertility and other medical conditions. Testimonials and personal experiences may be meaningful to the people sharing them, but they are not, by themselves, sufficient evidence that a product is safe and effective for treating a disease.
What questions remain unanswered?
The central issue is not whether people should attend a religious gathering or practise their faith. It is whether the public will receive clear, accurate information if Water of Life is presented as having medical benefits.
Several questions remain relevant ahead of the reported launch. What exactly is Water of Life? Is it a spiritual initiative or a physical product? If it is a product, what does it contain, who produces it and what is its intended use? If claims are made that it treats or cures illnesses, what evidence supports those claims, and what is its regulatory status?
A response from PHD Ministries would help establish the nature of the initiative and clarify any statements made about its purpose. MCAZ could independently address the regulatory questions if a medicine or complementary product is involved.
At the time of writing, the announcement identified above provides information about the planned launch, but it does not independently verify the alleged disease-cure claims circulating in public discussion. No official response from PHD Ministries or MCAZ is quoted in this article.
Transparency would benefit the public
Water of Life should be assessed on the basis of verifiable information rather than speculation, assumptions or conclusions drawn solely from the Aguma case.
For PHD Ministries, providing details about the initiative and clarifying any health-related claims would help the public understand what is being introduced. For regulators, any product or promotional claims falling within their mandate can be assessed against the relevant laws and standards.
For worshippers and the wider public, the most useful approach is to seek reliable information, avoid sharing unverified medical claims as fact and continue consulting qualified healthcare professionals about medical conditions.
The November 6 gathering may provide more information about Water of Life. Until the initiative is clearly described and any medical claims are independently assessed, however, its nature, effectiveness and regulatory position should not be assumed.
The public-interest question is straightforward: if Water of Life is promoted as a medical treatment, what evidence supports the claims, and has the product met the requirements that protect consumers? Clear answers would allow people to make informed decisions without dismissing religious faith or compromising public health.
